These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37813818)

  • 1. Development of Prodrug-Payloads for Targeted Therapeutic Applications of Platinum-Acridine Anticancer Agents.
    Mancera-Ortiz IY; Chen J; Slade TA; Yao X; Zhang S; Day CS; Bierbach U
    Bioconjug Chem; 2023 Oct; 34(10):1873-1881. PubMed ID: 37813818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.
    Yao X; Tracy CM; Bierbach U
    Inorg Chem; 2019 Jan; 58(1):43-46. PubMed ID: 30543413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Circulation and Tumor Accumulation of Carboplatin via an Erythrocyte-Anchored Prodrug Strategy.
    Yao H; Wang Z; Wang N; Deng Z; Liu G; Zhou J; Chen S; Shi J; Zhu G
    Angew Chem Int Ed Engl; 2022 Jun; 61(25):e202203838. PubMed ID: 35352863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.
    Ding S; Qiao X; Kucera GL; Bierbach U
    J Med Chem; 2012 Nov; 55(22):10198-203. PubMed ID: 23074987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity.
    Babak MV; Zhi Y; Czarny B; Toh TB; Hooi L; Chow EK; Ang WH; Gibson D; Pastorin G
    Angew Chem Int Ed Engl; 2019 Jun; 58(24):8109-8114. PubMed ID: 30945417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor-Targeted Therapeutically Enhanced Anticancer Therapy.
    Liang G; Sadhukhan T; Banerjee S; Tang D; Zhang H; Cui M; Montesdeoca N; Karges J; Xiao H
    Angew Chem Int Ed Engl; 2023 May; 62(22):e202301074. PubMed ID: 36961095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022.
    Su S; Chen Y; Zhang P; Ma R; Zhang W; Liu J; Li T; Niu H; Cao Y; Hu B; Gao J; Sun H; Fang D; Wang J; Wang PG; Xie S; Wang C; Ma J
    Eur J Med Chem; 2022 Dec; 243():114680. PubMed ID: 36152386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
    Gibson D
    J Inorg Biochem; 2021 Apr; 217():111353. PubMed ID: 33477089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells.
    Yao H; Xu Z; Li C; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2019 Aug; 58(16):11076-11084. PubMed ID: 31393117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer carrier-linked prodrugs in clinical trials.
    Kratz F; Abu Ajaj K; Warnecke A
    Expert Opin Investig Drugs; 2007 Jul; 16(7):1037-58. PubMed ID: 17594188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents.
    Ding S; Bierbach U
    Dalton Trans; 2016 Aug; 45(33):13104-13. PubMed ID: 27251881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
    Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
    Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer platinum (IV) prodrugs with novel modes of activity.
    Chin CF; Wong DY; Jothibasu R; Ang WH
    Curr Top Med Chem; 2011; 11(21):2602-12. PubMed ID: 22039869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitargeted Platinum(IV) Anticancer Complexes Bearing Pyridinyl Ligands as Axial Leaving Groups.
    Zhou Q; Chen S; Xu Z; Liu G; Zhang S; Wang Z; Tse MK; Yiu SM; Zhu G
    Angew Chem Int Ed Engl; 2023 Apr; 62(18):e202302156. PubMed ID: 36878864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general prodrug nanohydrogel platform for reduction-triggered drug activation and treatment of taxane-resistant malignancies.
    Yao J; Li T; Shi X; Wang Y; Fang S; Wang H
    Acta Biomater; 2021 Aug; 130():409-422. PubMed ID: 34087447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.
    Wallace PM; Senter PD
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):505-12. PubMed ID: 7885077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorescent probe for investigating the activation of anticancer platinum(IV) prodrugs based on the cisplatin scaffold.
    Montagner D; Yap SQ; Ang WH
    Angew Chem Int Ed Engl; 2013 Nov; 52(45):11785-9. PubMed ID: 24105908
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.
    Guddneppanavar R; Bierbach U
    Anticancer Agents Med Chem; 2007 Jan; 7(1):125-38. PubMed ID: 17266509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cytotoxicity and structure-activity relationships between ester and amide functionalities in novel acridine-based platinum(II) complexes.
    Bouyer F; Moretto J; Pertuit D; Szollosi A; Lacaille-Dubois MA; Blache Y; Chauffert B; Desbois N
    J Inorg Biochem; 2012 May; 110():51-7. PubMed ID: 22459174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.